Part D Expenses and Plan Limits

Medicare Part D is a prescription drug coverage program offered by private insurance companies that contract with Medicare. Part D Expenses and Plan Limits refers to the amount of money you and your plan pay for prescription drugs, as well as the maximum amount of money your plan will pay for your prescription drugs in a given year. Here are the key features of Part D Expenses and Plan Limits:

  • Monthly Premium: You will pay a monthly premium for your Part D coverage, which can vary depending on the plan you choose.

  • Annual Deductible: Some Part D plans have an annual deductible, which is the amount you must pay out of pocket before your plan begins to pay for your prescription drugs.

  • Co-payments/Co-insurance: Once you have met your deductible, you will typically pay a co-payment or co-insurance for each prescription drug you receive. Co-payments are a fixed dollar amount, while co-insurance is a percentage of the total cost of the drug.

  • Coverage Gap: The coverage gap, also known as the donut hole, is a temporary limit on prescription drug coverage. Once you and your plan have spent a certain amount on covered prescription drugs, you will enter the coverage gap, and your cost-sharing will increase until you reach the catastrophic coverage phase.

  • Catastrophic Coverage: Once you have spent a certain amount out-of-pocket for covered prescription drugs, you will enter the catastrophic coverage phase. During this phase, you will pay a reduced amount for your prescription drugs for the remainder of the year.

Example:

Let's say you have a Part D plan with a $400 deductible, a $25 co-payment for each generic drug, and a $200 co-payment for each brand-name drug. Your plan also has a coverage gap and a catastrophic coverage threshold.

If you need a generic medication that costs $50, you will pay the $25 co-payment, and your plan will pay the remaining $25. If you need a brand-name medication that costs $500, you will pay the $200 co-payment, and your plan will pay the remaining $300.

Once you and your plan have spent a total of $4,130 on covered prescription drugs, you will enter the coverage gap. While in the coverage gap, you will pay 25% of the cost of both brand-name and generic drugs. During this phase, you will pay a smaller amount for your prescription drugs for the remainder of the year.

It's important to note that the cost-sharing amounts and thresholds for Part D expenses and plan limits can vary between plans. It's important to review your plan's details and costs to understand how the plan limits and expenses will affect your prescription drug costs.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.